English
Baby Rabbit Complement Serum
Baby Rabbit Complement Serum
Artikelnummer
AVIOOSA10422
Verpackungseinheit
2ml
Hersteller
Aviva Systems Biology
Verfügbarkeit:
wird geladen...
Preis wird geladen...
Description of Target: Baby Rabbit Complement Serum
.
Key Reference: 1. Council of Europe. (1983) Essential aspects of tissue typing: Preparation, use, storage of reagents and standardisation of complement. European Health Committee, Strasbourg, ISBN 92-871.224-4.
2. Edited by J.G.Ray. (1979) NIAID Manual of tissue typing techniques . Publication No. NIH-80-545.
3. Anderson. L.D. Jr, et al. (1999) Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogenic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res. 59: 1525-1530.
4. Mason. J. et al. (2002) Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. Circ.Res. 91: 969-703.
5. Lidington. E. et al. (2000) Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement mediated injury. Blood. 96: 2784-2972.
6. De Clerq. L. et al. (1997) An anti-adipocyte monoclonal antibody is cytotoxic to porcine preadipocytes in vitro and depresses the development of pig adipose tissue. J.Anim. Sci. 75: 1791-1797.
.
Product Format: Lyophilized without stabilizers .
.
Key Reference: 1. Council of Europe. (1983) Essential aspects of tissue typing: Preparation, use, storage of reagents and standardisation of complement. European Health Committee, Strasbourg, ISBN 92-871.224-4.
2. Edited by J.G.Ray. (1979) NIAID Manual of tissue typing techniques . Publication No. NIH-80-545.
3. Anderson. L.D. Jr, et al. (1999) Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogenic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res. 59: 1525-1530.
4. Mason. J. et al. (2002) Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. Circ.Res. 91: 969-703.
5. Lidington. E. et al. (2000) Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement mediated injury. Blood. 96: 2784-2972.
6. De Clerq. L. et al. (1997) An anti-adipocyte monoclonal antibody is cytotoxic to porcine preadipocytes in vitro and depresses the development of pig adipose tissue. J.Anim. Sci. 75: 1791-1797.
.
Product Format: Lyophilized without stabilizers .
| Artikelnummer | AVIOOSA10422 |
|---|---|
| Hersteller | Aviva Systems Biology |
| Hersteller Artikelnummer | OOSA10422-2 |
| Green Labware | Nein |
| Verpackungseinheit | 2ml |
| Mengeneinheit | STK |
| Methode | Functional Assay, Immunoassay |
| Produktinformation (PDF) |
|
| MSDS (PDF) |
|
Immer für Sie da
Gernot Ensinger, M.Sc.
